Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-03

Clinical Trial Update: SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of SteRilizing Eye Solution for retinal disease completed; results update released.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SteRilizing Eye Solution

Snippet

Sponsor: iRenix Medical, Inc. | Conditions: Retinal Disease | Phase 2 | Status: COMPLETED